国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2012年
13期
1968-1970
,共3页
心力衰竭%氨基末端脑钠肽前体%护理干预%MHL评分
心力衰竭%氨基末耑腦鈉肽前體%護理榦預%MHL評分
심력쇠갈%안기말단뇌납태전체%호리간예%MHL평분
Heart failure%Amino-terminal pro-brain natriuretic peptide%Nursing intervention%MHL score
目的 了解心力衰竭(CHF)患者血浆N端脑钠肽前体(NT-proBNP)的水平及探讨护理干预对慢性CHF患者的影响.方法 测定150例CHF患者和140例正常组血清NT-proBNP水平:将150例慢性CHF患者随机分成干预组和对照组,对照组给予住院期间常规药物治疗及护理,干预组在此基础上进行护理干预.采用明尼苏达生活质量量表(MHL评分)评价两组病人干预前后生活质量的改变.结果 CHF患者血中NT-proBNP水平明显高于对照组(P＜0.01),两组CHF患者在护理干预前生活质量无明显差异(P＞0.05),护理干预后两组患者生活质量有明显差异(P＜0.05).结论 血浆NT-proBNP水平对于早期判断心功能不全的程度有参考意义,实施护理干预可以提高CHF患者的生活质量.
目的 瞭解心力衰竭(CHF)患者血漿N耑腦鈉肽前體(NT-proBNP)的水平及探討護理榦預對慢性CHF患者的影響.方法 測定150例CHF患者和140例正常組血清NT-proBNP水平:將150例慢性CHF患者隨機分成榦預組和對照組,對照組給予住院期間常規藥物治療及護理,榦預組在此基礎上進行護理榦預.採用明尼囌達生活質量量錶(MHL評分)評價兩組病人榦預前後生活質量的改變.結果 CHF患者血中NT-proBNP水平明顯高于對照組(P＜0.01),兩組CHF患者在護理榦預前生活質量無明顯差異(P＞0.05),護理榦預後兩組患者生活質量有明顯差異(P＜0.05).結論 血漿NT-proBNP水平對于早期判斷心功能不全的程度有參攷意義,實施護理榦預可以提高CHF患者的生活質量.
목적 료해심력쇠갈(CHF)환자혈장N단뇌납태전체(NT-proBNP)적수평급탐토호리간예대만성CHF환자적영향.방법 측정150례CHF환자화140례정상조혈청NT-proBNP수평:장150례만성CHF환자수궤분성간예조화대조조,대조조급여주원기간상규약물치료급호리,간예조재차기출상진행호리간예.채용명니소체생활질량량표(MHL평분)평개량조병인간예전후생활질량적개변.결과 CHF환자혈중NT-proBNP수평명현고우대조조(P＜0.01),량조CHF환자재호리간예전생활질량무명현차이(P＞0.05),호리간예후량조환자생활질량유명현차이(P＜0.05).결론 혈장NT-proBNP수평대우조기판단심공능불전적정도유삼고의의,실시호리간예가이제고CHF환자적생활질량.
Objective To understand the plasma of patients with N terminal pro brain natfiuretic peptide ( NTproBNP ) level in patients with chronic heart failure (CHF) and explore the effect on nursing intervention on these patients.Methods The serum NT-proBNP level 150 patients with CHF and 140 cases of control group were determined.The 150CHF patients were randomly divided into intervention group and control group.Control group wns given routine treatment and nursing care during hospitalization.Basing on control group's treatment,intervention group were given nursing intervention.The Minnesota quality of life scale ( MHL score) was used to evaluate the life quality of all patients in both groups before and after treatment.Results The blood NT-proBNP was significantly higher in intervention group than in control group ( P ＜ 0.01) after treatment.Before treatment,there was no difference in life quality between the two groups.However,after treatment,life quality was significantly better in intervention group than in control group.Conclusions Plasma NTproBNP has reference significance for the early determination of the severity of heart failure.Nursing intervention can improve CHF patients' life quality.
